Selling the company and having Amgen push trials through is the most only reasonable option. There have been TOO many delays/missteps by mgmt and bod. Bp has the experience and financial resources to make the science successful. Does the company need another CEO to make another attempt at success. After all of these years the answer is evident...SELL the company. $2B is a steal with $800m in deals and HOT + other constructs.
Market Data 
Markets 
AI
